 Comparison dexamethasone ondansetron prophylaxis emesis emetogenic chemotherapy multicentre double-blind cross-over trial efficacy safety serotonin receptor antagonist ondansetron dexamethasone prophylaxis acute emesis nausea emetogenic non-platinum-containing chemotherapy regimens Patients outpatients intravenous mg dexamethasone mg chemotherapy oral maintenance mg dexamethasone mg mg days days patients men women gender age range years evaluable cross-over analysis Patients ondansetron dexamethasone significant difference complete major control acute vs vs emesis retches patients dexamethasone ondansetron control delayed nausea days drugs significant difference number adverse events similar patient preference ondansetron dexamethasone drugs adequate out-patient control chemotherapy-induced emesis dexamethasone advantage control delayed nausea terms cost resource allocation